SpectraScience Schedules Business Update Conference Call
(firmenpresse) - SAN DIEGO, CA -- (Marketwire) -- 03/28/13 -- SpectraScience, Inc. (OTCQB: SCIE) today announced that the Company will hold a conference call at 4:30 p.m. Eastern (1:30 p.m. Pacific) on April 5th to provide an update on its business.
To access the call, please dial 877-293-5456 and provide the Conference ID: 30821575. The conference call will also be broadcast live via the Internet and can be accessed via link through the "Investor Relations" page of the Company's website, .
At the conclusion of the call, a replay will be available until April 11th 2013. To access the replay of the call dial (855) 859-2056 and provide the same Conference ID. A webcast archive will be available at shortly after the call as well.
SpectraScience is a San Diego based medical device company that designs, develops, manufactures and markets light-based analysis systems capable of determining whether tissue is normal, pre-cancerous or cancerous without physically removing tissue from the body. The WavSTAT Optical Biopsy System uses light to optically diagnose tissue and provide the physician with an immediate analysis. With approval for sale under the CE Mark for the European Union, the WavSTAT System is the first commercially available product that incorporates this innovative technology for clinical use.
Contact:
SpectraScience, Inc.
Jim Dorst
Chief Financial Officer
(858) 405-9933
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 28.03.2013 - 21:00 Uhr
Sprache: Deutsch
News-ID 244324
Anzahl Zeichen: 7868
contact information:
Town:
SAN DIEGO, CA
Kategorie:
Commercial & Investment Banking
Diese Pressemitteilung wurde bisher 236 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"SpectraScience Schedules Business Update Conference Call"
steht unter der journalistisch-redaktionellen Verantwortung von
SpectraScience, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
